Key gp120 Glycans Pose Roadblocks to the Rapid Development of VRC01-Class Antibodies in an HIV-1-Infected Chinese Donor.
Kong, L., Ju, B., Chen, Y., He, L., Ren, L., Liu, J., Hong, K., Su, B., Wang, Z., Ozorowski, G., Ji, X., Hua, Y., Chen, Y., Deller, M.C., Hao, Y., Feng, Y., Garces, F., Wilson, R., Dai, K., O'Dell, S., McKee, K., Mascola, J.R., Ward, A.B., Wyatt, R.T., Li, Y., Wilson, I.A., Zhu, J., Shao, Y.(2016) Immunity 44: 939-950
- PubMed: 27067056 
- DOI: 10.1016/j.immuni.2016.03.006
- Primary Citation of Related Structures:  
5CD3, 5CD5 - PubMed Abstract: 
VRC01-class antibodies neutralize diverse HIV-1 strains by targeting the conserved CD4-binding site. Despite extensive investigations, crucial events in the early stage of VRC01 development remain elusive. We demonstrated how VRC01-class antibodies emerged in a Chinese donor by antigen-specific single B cell sorting, structural and functional studies, and longitudinal antibody and virus repertoire analyses ...